Survey of aspergillosis in non-neutropenic patients in Swiss teaching hospitals
- PMID: 20950331
- DOI: 10.1111/j.1469-0691.2010.03402.x
Survey of aspergillosis in non-neutropenic patients in Swiss teaching hospitals
Abstract
Invasive aspergillosis (IA) is a live-threatening opportunistic infection that is best described in haematological patients with prolonged neutropenia or graft-versus-host disease. Data on IA in non-neutropenic patients are limited. The aim of this study was to establish the incidence, disease manifestations and outcome of IA in non-neutropenic patients diagnosed in five Swiss university hospitals during a 2-year period. Case identification was based on a comprehensive screening of hospital records. All cases of proven and probable IA were retrospectively analysed. Sixty-seven patients were analysed (median age 60 years; 76% male). Sixty-three per cent of cases were invasive pulmonary aspergillosis (IPA), and 17% of these were disseminated aspergillosis. The incidence of IPA was 1.2/10 000 admissions. Six of ten cases of extrapulmonary IA affected the brain. There were six cases of invasive rhinosinusitis, six cases of chronic pulmonary aspergillosis, and cases three of subacute pulmonary aspergillosis. The most frequent underlying condition of IA was corticosteroid treatment (57%), followed by chronic lung disease (48%), and intensive-care unit stays (43%). In 38% of patients with IPA, the diagnosis was established at autopsy. Old age was the only risk factor for post-mortem diagnosis, whereas previous solid organ transplantation and chronic lung disease were associated with lower odds of post-mortem diagnosis. The mortality rate was 57%.
© 2010 The Authors. Clinical Microbiology and Infection © 2010 European Society of Clinical Microbiology and Infectious Diseases.
Similar articles
-
Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.J Pediatr Hematol Oncol. 2009 Sep;31(9):642-6. doi: 10.1097/MPH.0b013e3181acd956. J Pediatr Hematol Oncol. 2009. PMID: 19684521
-
Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey.Clin Infect Dis. 2006 Sep 1;43(5):577-84. doi: 10.1086/505870. Epub 2006 Jul 27. Clin Infect Dis. 2006. PMID: 16886149
-
Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.Bone Marrow Transplant. 2002 Jan;29(1):15-9. doi: 10.1038/sj.bmt.1703332. Bone Marrow Transplant. 2002. PMID: 11840139
-
Invasive aspergillosis in developing countries.Med Mycol. 2011 Apr;49 Suppl 1:S35-47. doi: 10.3109/13693786.2010.505206. Epub 2010 Aug 18. Med Mycol. 2011. PMID: 20718613 Review.
-
How to manage aspergillosis in non-neutropenic intensive care unit patients.Crit Care. 2014 Jul 25;18(4):458. doi: 10.1186/s13054-014-0458-4. Crit Care. 2014. PMID: 25167934 Free PMC article. Review.
Cited by
-
The clinical spectrum of aspergillosis in chronic obstructive pulmonary disease.Infection. 2023 Aug;51(4):813-829. doi: 10.1007/s15010-022-01960-2. Epub 2023 Jan 20. Infection. 2023. PMID: 36662439 Free PMC article. Review.
-
How Has the Aspergillosis Case Fatality Rate Changed over the Last Two Decades in Spain?J Fungi (Basel). 2022 May 27;8(6):576. doi: 10.3390/jof8060576. J Fungi (Basel). 2022. PMID: 35736059 Free PMC article.
-
Limited Index of Clinical Suspicion and Underdiagnosis of Histopathologically Documented Invasive Mold Infections.Open Forum Infect Dis. 2021 Apr 2;8(7):ofab174. doi: 10.1093/ofid/ofab174. eCollection 2021 Jul. Open Forum Infect Dis. 2021. PMID: 34549073 Free PMC article.
-
A patient with hepatocellular carcinoma who developed invasive pulmonary aspergillosis after corticosteroid treatment.Clin Case Rep. 2021 Aug 10;9(8):e04628. doi: 10.1002/ccr3.4628. eCollection 2021 Aug. Clin Case Rep. 2021. PMID: 34401173 Free PMC article.
-
Therapeutic effects of pentoxifylline on invasive pulmonary aspergillosis in immunosuppressed mice.BMC Pulm Med. 2021 Jan 19;21(1):31. doi: 10.1186/s12890-021-01396-8. BMC Pulm Med. 2021. PMID: 33468116 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical